On May 08, 2015 , The USPTO issued the U.S. Patent Number 8798753 to EndoStim, Inc., which was successfully prosecuted by Novel IP.
The '753 patent is directed towards the implantable stimulation device for use in stimulation based treatments for diseases such as GERD or obesity is described. The device is provided with an anchoring unit which upon deployment assumes a shape optimized for the site of deployment. Sensing electrodes and stimulating electrodes in the device are also designed to assume a suitable shape upon deployment. A novel catheter is also provided for easy and expeditious deployment of the device.